Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000945621-13-000132
Filing Date
2013-03-25
Accepted
2013-03-25 12:54:01
Documents
1
Effectiveness Date
2013-03-25
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 17129
  Complete submission text file 0000945621-13-000132.txt   18169
Mailing Address 139 SOUTH STREET, SUITE 102 NEW PROVIDENCE NJ 07974
Business Address 139 SOUTH STREET, SUITE 102 NEW PROVIDENCE NJ 07974 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-193853 | Film No.: 13713475